Travere Therapeutics Inc Stock Performance
as on September 18, 2025 at 1:29 am IST
Day's Low
Day's High
$22.65$23.77
4.27%
Downside
0.46%
Upside
52 Week's Low
52 Week's High
$12.91$28.6945.44%
Downside
21.27%
Upside
Travere Therapeutics Inc share price movements today
- Previous Close
- $22.77
- Open
- $23.12
- Volume
- 1.3M
- Day's Low - High
- $22.65 - $23.77
- 52 Week Low - High
- $12.91 - $28.69
Travere Therapeutics Inc Historical Returns
- 1 Month Return
- + 20.99 %
- 3 Month Return
- + 61.66 %
- 1 Year Return
- + 58.12 %
- 3 Year Return
- -14.3 %
- 5 Year Return
- + 15.76 %
Travere Therapeutics Inc Stock Fundamentals & Key Indicators
Check Travere Therapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$2.1B
EPS (TTM)
-0.1863
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
0P/B Ratio
0PEG Ratio
0EBITDA
-120.5M
Revenue (TTM)
333.9M
Profit Margin
-50.64%
Return On Equity TTM
792000.00%
Travere Therapeutics Inc vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Travere Therapeutics Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $2.1B | 15.76% | NA | -50.64% | |
| BUY | $60.5B | 252.04% | -505.15 | -12.96% | |
| NA | $39.0B | NA | NA | -3.89% | |
| BUY | $100.3B | 44.17% | 27.85 | 31.86% | |
| BUY | $59.6B | 1.78% | 14.1 | 31.37% |
Stock Returns calculator for Travere Therapeutics Inc Stock including INR - Dollar returns
The Travere Therapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Travere Therapeutics Inc investment value today
Current value as on today
₹1,68,904
Returns
₹68,904
(+68.9%)
Returns from Travere Therapeutics Inc Stock
₹64,306 (+64.31%)
Dollar Returns*
₹4,598 (+4.6%)
Analyst Recommendation on Travere Therapeutics Inc Stock
Based on 22 analysts
72.73%
Buy
27.27%
Hold
0.00%
Sell
Based on 22 analysts, 72.73% of analysts recommend a 'BUY' rating for Travere Therapeutics Inc. Average target price of $36
Travere Therapeutics Inc Share Price Target
Get share price movements and forecasts by analysts on Travere Therapeutics Inc.
What analysts predicted
34.28%UPSIDE
Target Price
$36
Current Price
$23.66
Analyzed by
22 Analysts
Target
$36.00
Travere Therapeutics Inc target price $36, a slight upside of 34.28% compared to current price of $23.66. According to 22 analysts rating.
Travere Therapeutics Inc Stock's Interest Amongst Investors
Search interest for Travere Therapeutics Inc Stock has increased by 833% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:833% versus previous 30 day period
Travere Therapeutics Inc Quarterly Profit & Loss
All numbers in Millions USD
Travere Therapeutics Inc Annual Profit & Loss
All numbers in Millions USD
Travere Therapeutics Inc Quarterly Cash Flow
All numbers in Millions USD
Travere Therapeutics Inc Annual Cash Flow
All numbers in Millions USD
Global Institutional Holdings in Travere Therapeutics Inc
Travere Therapeutics Inc News & Key Events
Today's Timeline - 11 September
Thu, 04:33 PM
-Wells Fargo raises Travere Therapeutics price target to $35, citing increased confidence in FSGS approval.
Insights on Travere Therapeutics Inc
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 6 quarters, 41.37M → 114.44M (in $), with an average increase of 18.1% per quarter
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 3 quarters, -60.26M → -12.75M (in $), with an average increase of 134.7% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 68.9% return, outperforming this stock by 10.2%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 116.5% return, outperforming this stock by 130.8%
NEGATIVE IMPACTPrice Dip
In the last 7 days, TVTX stock has moved down by -8.9%
About Travere Therapeutics Inc
| Organisation | Travere Therapeutics Inc |
| Headquarters | 3611 Valley Centre Drive, San Diego, CA, United States, 92130 |
| Industry | Health Technology |
| CEO | Dr. Eric M. Dube Ph.D. |
| E-voting on shares | Click here to vote |
Key Management of Travere Therapeutics Inc
Name | Title |
|---|---|
Mr. Christopher Cline C.F.A. | Chief Financial Officer |
Dr. William E. Rote Ph.D. | Chief Research Officer |
Mr. Peter Heerma | Chief Commercial Officer |
Dr. Jula Inrig M.D. | Chief Medical Officer |
Ms. Elizabeth E. Reed J.D. | Chief Legal Officer, General Counsel & Secretary |
Dr. Eric M. Dube Ph.D. | President, CEO & Director |
Ms. Nivi Nehra | Vice President of Corporate Communications & Investor Relations |
Ms. Angela Giannantonio | Chief People Officer |
Mr. Casey Logan | Chief Business Officer |
Ms. Sandra Calvin | SVP, Corporate Controller & Chief Accounting Officer |
FAQs
What is Travere Therapeutics Inc share price today?
Travere Therapeutics Inc share price today is $23.66 as on at the close of the market. Travere Therapeutics Inc share today touched a day high of $23.77 and a low of $22.65.
What is the 52 week high and 52 week low for Travere Therapeutics Inc share?
Travere Therapeutics Inc share touched a 52 week high of $28.69 on and a 52 week low of $12.91 on . Travere Therapeutics Inc stock price today i.e. is closed at $23.66,which is 17.54% down from its 52 week high and 83.27% up from its 52 week low.
What is Travere Therapeutics Inc's market capitalisation today?
Travere Therapeutics Inc market capitalisation is $0.00T as on .
How to invest in Travere Therapeutics Inc Stock (TVTX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Travere Therapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Travere Therapeutics Inc Shares that will get you 0.0634 shares as per Travere Therapeutics Inc share price of $23.66 per share as on September 18, 2025 at 1:29 am IST.
What is the minimum amount required to buy Travere Therapeutics Inc Stock (TVTX) from India?
Indian investors can start investing in Travere Therapeutics Inc (TVTX) shares with as little as ₹87.816 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹878.16 in Travere Therapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Travere Therapeutics Inc share’s latest price of $23.66 as on September 18, 2025 at 1:29 am IST, you will get 0.4227 shares of Travere Therapeutics Inc. Learn more about
fractional shares .
What are the returns that Travere Therapeutics Inc has given to Indian investors in the last 5 years?
Travere Therapeutics Inc stock has given 15.76% share price returns and 20.01% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?